Resources with keywords: Oropouche



Oropouche virus: Infectious substances pathogen safety data sheet
Public Health Agency of Canada
Oropouche virus VR-266
ATCC

ATCC is a repository of biological materials. This is a sample from Trinidad.

Reemergence of Oropouche Virus in the Americas and Risk for Spread in the United States and Its Territories, 2024
CDC / Emerging Infectious Diseases
1 October 2024

Guagliardo SJ, Connelly C, Lyons S, Martin SW, Sutter R, Hughes HR, et al.
Reviews information on Oropouche virus, factors influencing its spread, transmission risk in the United States, and current status of public health response tools.

Important Information for Blood Establishments Regarding the Oropouche Virus and Blood Donation
FDA
13 September 2024

Worldwide, there have been no reports of transmission of OROV by transfusion of blood or blood components. FDA will continue to monitor cases of OROV disease in the U.S. and worldwide and will issue updated information as it becomes available.

Oropouche Virus Disease Among U.S. Travelers — United States, 2024
CDC / MMWR
5 September 2024
Oropouche virus disease - Region of the Americas
World Health Organization (WHO)
23 August 2024
Increased Oropouche Virus Activity and Associated Risk to Travelers
CDC / Health Alert Network (HAN)
16 August 2024

Includes information for travelers, Health Departments and testing laboratories.

Oropouche virus disease cases imported into the European Union
European Centre for Disease Prevention and Control (ECDC) / THREAT ASSESSMENT BRIEF
9 August 2024

Includes epidemiological information and risk assessment considerations

Public Health Risk Assessment related to Oropouche Virus (OROV) in the Region of the Americas - 9 February 2024
PAHO/WHO
9 February 2024

A very thorough detailed risk assessment profile for Oropouche Virus.

Oropouche Fever: A Review
Viruses
4 April 2024

Sakkas H, Bozidis P, Franks A, Papadopoulou C.

Go to Top